Parul Kamboj, Geeti Khullar, Sanjeev Handa, Arnab Pal, Uma Nahar Saikia, Dipankar De
{"title":"Role of <i>FoxO1</i> in Acne and Effect of Isotretinoin on <i>FoxO1</i> Expression.","authors":"Parul Kamboj, Geeti Khullar, Sanjeev Handa, Arnab Pal, Uma Nahar Saikia, Dipankar De","doi":"10.4103/idoj.idoj_455_23","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Nodulocystic acne is a severe type of acne that is known to improve after treatment with isotretinoin. Melnik has hypothesized a unifying concept on the mechanism of acne pathogenesis involving altered expression of Forkhead box O transcription factor (<i>FoxO1</i>) and role of isotretinoin in improving acne via modulating this pathway.</p><p><strong>Aim: </strong>To evaluate the pathway proposed by Melnik in acne pathogenesis by analysing the difference in the expression of <i>FoxO1</i>, peroxisome proliferator-activated receptor (<i>PPARγ</i>), and androgen receptor (AR) between acne patients and non-acne controls and the effect of treatment with isotretinoin on change in expression of these genes in acne patients.</p><p><strong>Results: </strong>The gene expression of <i>FoxO1</i> was non significantly higher in acne patients as compared to controls. After treatment with isotretinoin, a significant decrease in <i>FoxO1</i> expression in acne patients at mRNA (<i>P</i> = 0.05) level was observed. There was a significant decrease in grade 3 positivity of <i>FoxO1</i> at protein level (<i>P</i> = 0.0009). A decrease in androgen receptor positivity (<i>P</i> = 0.055) at protein level was also observed.</p><p><strong>Conclusion: </strong>Reduction in <i>FoxO1</i> expression appears to be an important mechanism of action of isotretinoin in acne.</p>","PeriodicalId":13335,"journal":{"name":"Indian Dermatology Online Journal","volume":"15 2","pages":"252-254"},"PeriodicalIF":1.9000,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10969248/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Dermatology Online Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/idoj.idoj_455_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Nodulocystic acne is a severe type of acne that is known to improve after treatment with isotretinoin. Melnik has hypothesized a unifying concept on the mechanism of acne pathogenesis involving altered expression of Forkhead box O transcription factor (FoxO1) and role of isotretinoin in improving acne via modulating this pathway.
Aim: To evaluate the pathway proposed by Melnik in acne pathogenesis by analysing the difference in the expression of FoxO1, peroxisome proliferator-activated receptor (PPARγ), and androgen receptor (AR) between acne patients and non-acne controls and the effect of treatment with isotretinoin on change in expression of these genes in acne patients.
Results: The gene expression of FoxO1 was non significantly higher in acne patients as compared to controls. After treatment with isotretinoin, a significant decrease in FoxO1 expression in acne patients at mRNA (P = 0.05) level was observed. There was a significant decrease in grade 3 positivity of FoxO1 at protein level (P = 0.0009). A decrease in androgen receptor positivity (P = 0.055) at protein level was also observed.
Conclusion: Reduction in FoxO1 expression appears to be an important mechanism of action of isotretinoin in acne.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
